Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment
Ana Hernández-Guío,
Miguel Ángel Calleja-Hernández,
Andrés Corno-Caparrós,
Marta Zayas-Soriano,
Mª Ángeles Bernabéu-Martínez,
Fernando Gutiérrez-Nicolás
Affiliations
Ana Hernández-Guío
Department of Pharmacy, San Juan de Alicante University Hospital, N-332, s/n, 03550, Sant Joan d'Alacant, Alicante, Spain; Corresponding author.
Miguel Ángel Calleja-Hernández
Department of Pharmacy, Virgen Macarena University Hospital, Sevilla, Av. Dr. Fedriani, 3, 41009, Seville, Spain
Andrés Corno-Caparrós
Miguel Hernández University, Elche, Avinguda de la Universitat d'Elx, s/n, 03202, Elche, Alicante, Spain
Marta Zayas-Soriano
Department of Pharmacy, San Juan de Alicante University Hospital, N-332, s/n, 03550, Sant Joan d'Alacant, Alicante, Spain
Mª Ángeles Bernabéu-Martínez
Department of Pharmacy, San Juan de Alicante University Hospital, N-332, s/n, 03550, Sant Joan d'Alacant, Alicante, Spain
Fernando Gutiérrez-Nicolás
Instituto de Investigación Sanitaria de Canarias, Carretera Gral. La Cuesta-Taco, n.s/n Pabellón de Gobierno del HUC Planta -1ª, 38320, San Cristobal de La Laguna, Santa Cruz de, Tenerife, Spain
